Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome

NCT02247947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-11-04

No results posted yet for this study

Summary

Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Conditions

  • Cardiac Arrest

Sponsors & Collaborators

  • Universitätsklinikum Köln

    lead OTHER

Principal Investigators

  • Jochen Hinkelbein, MD · UK Köln

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2020-11-01
Completion
2020-11-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247947 on ClinicalTrials.gov